These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10968901)

  • 41. Hyperhomocysteinemia relates to the subtype of antiphospholipid antibodies in non-SLE patients.
    Chen WH; Lin HS; Kao YF; Lan MY; Liu JS
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):398-403. PubMed ID: 17911191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
    Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
    Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?
    Harris EN; Pierangeli SS
    Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
    J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Combined therapy in pregnancy with primary antiphospholipid syndrome].
    Szodoray P; Bacskó G; Lakos G; Zeher M
    Orv Hetil; 2003 Dec; 144(49):2411-3. PubMed ID: 14725207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiphospholipid antibody syndrome and fetal outcome.
    Djelmis J; Radoncić E; Ivanisević M
    Acta Med Croatica; 2001; 55(3):123-30. PubMed ID: 11852731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk?
    Galli M
    Thromb Res; 2004; 114(5-6):597-601. PubMed ID: 15507297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J; Swadzba J; Motyl A; Iwaniec T
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mothers' antiphospholipid antibodies during pregnancy and the relation to offspring outcome.
    Mekinian A; Carbillon L; Nicaise-Roland P; Rousseau H; Lachassinne E; Motta M; Vicaut E; Boinot C; Avcin T; De Carolis S; Rovere-Querini P; Lambert M; Derenne S; Pourrat O; Chollet-Martin S; Biasini-Rebaioli R; Rovelli R; Lojacono A; Ambrozic A; Benbara A; Pierre F; Allegri F; Nuzzo M; Hatron PY; Tincani A; Aurousseau MH; Boffa MC; Fain O
    Clin Exp Rheumatol; 2014; 32(3):446. PubMed ID: 24847815
    [No Abstract]   [Full Text] [Related]  

  • 51. [Antiphospholipid antibodies and pregnancy].
    Kdous M; Hachicha R; Lombroso R; Gallardo G
    Tunis Med; 2005 Jan; 83(1):1-5. PubMed ID: 15881713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The primary, secondary, catastrophic, and seronegative variants of the antiphospholipid syndrome: a personal history long in the making.
    Asherson RA
    Semin Thromb Hemost; 2008 Apr; 34(3):227-35. PubMed ID: 18720302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiphospholipid antibody syndrome.
    Khamashta MA
    Isr J Med Sci; 1994 Mar; 30(3):19-21. PubMed ID: 8181919
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antiphospholipid syndrome].
    Ohkubo T
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():706-10. PubMed ID: 26480781
    [No Abstract]   [Full Text] [Related]  

  • 56. Antiphospholipid antibodies and thrombosis.
    Gleicher N; Coulam C
    Lancet; 1999 Jul; 354(9172):72-3. PubMed ID: 10406388
    [No Abstract]   [Full Text] [Related]  

  • 57. Optimizing the management of thrombosis in the antiphospholipid-antibody syndrome.
    Haematologica; 1999 Dec; 84(12):1057. PubMed ID: 10586203
    [No Abstract]   [Full Text] [Related]  

  • 58. Nailfold videocapillaroscopy abnormalities in patients with antiphospholipid antibodies.
    Sulli A; Pizzorni C; Cutolo M
    J Rheumatol; 2000 Jun; 27(6):1574-6. PubMed ID: 10852305
    [No Abstract]   [Full Text] [Related]  

  • 59. A prospective epidemiological study on the occurrence of antiphospholipid antibody: the Montpellier Antiphospholipid (MAP) Study.
    Schved JF; Dupuy-Fons C; Biron C; Quére I; Janbon C
    Haemostasis; 1994; 24(3):175-82. PubMed ID: 7988947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology of Antiphospholipid Syndrome in the General Population.
    Dabit JY; Valenzuela-Almada MO; Vallejo-Ramos S; Duarte-García A
    Curr Rheumatol Rep; 2022 Jan; 23(12):85. PubMed ID: 34985614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.